Italian Association Amici di Raoul Follereau (AIFO)

Contact

General

Project Support

Alliances & Links

Resources & Training

ARCHIVES OF LEPROSY MAILING LIST
Archives of recent messages from Leprosy Mailing List (LML) managed by Dr Salvatore Noto.

Over the past few years, LML moderated by Dr Noto has become one of the most important online resource for promoting discussions about leprosy.

Contact LML Objectives of LML LML Archives

Leprosy Mailing List – March 8th, 2007

 

Ref.:    Corticosteroids in leprosy reactions.

From:   Ahmad L., Karachi, Pakistan


 

 

Dear Salvatore,

 

de Soldenhoff's comments (LML Feb. 19th, 2007) on Grace Warren's paper (LML Jan. 11th, 2007) are very interesting indeed.  Grace Warren's paper contains advises on the managements of reactions in leprosy and covers almost everything, but only medical graduates and doctors working in leprosy can understand it, HOWEVER, situation on the ground is a bit different.  Leprosy technicians can only follow guidelines given to them, alteration of such guidelines from time to time will only create confusion especially when they are asked to rule out concomitant diseases (for which they are not trained).  Tuberculosis is the only disease which they can rule out by doing sputum smears for AFBs for which they do have facilities YET, secretions from nasopharynx of an active lepromatous patients does contain AFBs.  I have seen many of such patients who were wrongly put on anti-tuberculosis treatment.  Here in Pakistan, apart from tuberculosis, malnutrition / anaemia, Malaria (which remains endemic throughout the year and epidemics twice a year), Hepatitis B and C, seasonal epidemics of other viral and bacterial infections are common.

 

As far as dose of corticosteroids for a certain length of time is concerned, we all know that type one and type two reactions are different from each other in their clinical presentation and histopathology HENSE require different regimens of corticosteroids for different length of time. The intensity of reaction in each type differ from one individual to another BUT, the rule of the thumb is that corticosteroids should be given sufficiently for sufficient time.

 

In my experience as leprosy worker I would try to avoid corticosteroids in type 2 (ENL) reaction as far as possible unless patient has acute neuritis, acute anterior uveitis, orchitis or any other sign of acute nerve damage.  Painful dermal nodules and periosteal tenderness can be dealt with NSAIDs in combination with other drugs mentioned in Dr Warren's article.

 

Leprosy technicians who start corticosteroids should consult doctor regularly for dose and duration of treatment.

 

With best wishes,

 

Dr Latif Ahmad

 

 

<< BACK TO LML ARCHIVE INDEX

 

AIFO, Via Borselli 4-6, 40135 Bologna, Italy
Tel: +390-51-4393.211 Fax: +390-51-434046 Email: info@aifo.it